Skip to main navigation Skip to search Skip to main content

T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation

  • Naoya Katsuyama
  • , Takakazu Kawase
  • , Carolyne Barakat
  • , Shohei Mizuno
  • , Akihiro Tomita
  • , Kazutaka Ozeki
  • , Nobuhiro Nishio
  • , Yoshie Sato
  • , Ryoko Kajiya
  • , Keiko Shiraishi
  • , Yoshiyuki Takahashi
  • , Tatsuo Ichinohe
  • , Hiroyoshi Nishikawa
  • , Yoshiki Akatsuka

Research output: Contribution to journal › Article › peer-review

3   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Immunology and Microbiology

Keyphrases